Cargando…

Epigenetics in diabetic nephropathy, immunity and metabolism

When it comes to the epigenome, there is a fine line between clarity and confusion—walk that line and you will discover another fascinating level of transcription control. With the genetic code representing the cornerstone of rules for information that is encoded to proteins somewhere above the geno...

Descripción completa

Detalles Bibliográficos
Autores principales: Keating, Samuel T., van Diepen, Janna A., Riksen, Niels P., El-Osta, Assam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448927/
https://www.ncbi.nlm.nih.gov/pubmed/29128937
http://dx.doi.org/10.1007/s00125-017-4490-1
_version_ 1783408757992062976
author Keating, Samuel T.
van Diepen, Janna A.
Riksen, Niels P.
El-Osta, Assam
author_facet Keating, Samuel T.
van Diepen, Janna A.
Riksen, Niels P.
El-Osta, Assam
author_sort Keating, Samuel T.
collection PubMed
description When it comes to the epigenome, there is a fine line between clarity and confusion—walk that line and you will discover another fascinating level of transcription control. With the genetic code representing the cornerstone of rules for information that is encoded to proteins somewhere above the genome level there is a set of rules by which chemical information is also read. These epigenetic modifications show a different side of the genetic code that is diverse and regulated, hence modifying genetic transcription transiently, ranging from short- to long-term alterations. While this complexity brings exquisite control it also poses a formidable challenge to efforts to decode mechanisms underlying complex disease. Recent technological and computational advances have improved unbiased acquisition of epigenomic patterns to improve our understanding of the complex chromatin landscape. Key to resolving distinct chromatin signatures of diabetic complications is the identification of the true physiological targets of regulatory proteins, such as reader proteins that recognise, writer proteins that deposit and eraser proteins that remove specific chemical moieties. But how might a diverse group of proteins regulate the diabetic landscape from an epigenomic perspective? Drawing from an ever-expanding compendium of experimental and clinical studies, this review details the current state-of-play and provides a perspective of chromatin-dependent mechanisms implicated in diabetic complications, with a special focus on diabetic nephropathy. We hypothesise a codified signature of the diabetic epigenome and provide examples of prime candidates for chemical modification. As for the pharmacological control of epigenetic marks, we explore future strategies to expedite and refine the search for clinically relevant discoveries. We also consider the challenges associated with therapeutic strategies targeting epigenetic pathways. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-017-4490-1) contains a slideset of the figures for download, which is available to authorised users.
format Online
Article
Text
id pubmed-6448927
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64489272019-04-17 Epigenetics in diabetic nephropathy, immunity and metabolism Keating, Samuel T. van Diepen, Janna A. Riksen, Niels P. El-Osta, Assam Diabetologia Review When it comes to the epigenome, there is a fine line between clarity and confusion—walk that line and you will discover another fascinating level of transcription control. With the genetic code representing the cornerstone of rules for information that is encoded to proteins somewhere above the genome level there is a set of rules by which chemical information is also read. These epigenetic modifications show a different side of the genetic code that is diverse and regulated, hence modifying genetic transcription transiently, ranging from short- to long-term alterations. While this complexity brings exquisite control it also poses a formidable challenge to efforts to decode mechanisms underlying complex disease. Recent technological and computational advances have improved unbiased acquisition of epigenomic patterns to improve our understanding of the complex chromatin landscape. Key to resolving distinct chromatin signatures of diabetic complications is the identification of the true physiological targets of regulatory proteins, such as reader proteins that recognise, writer proteins that deposit and eraser proteins that remove specific chemical moieties. But how might a diverse group of proteins regulate the diabetic landscape from an epigenomic perspective? Drawing from an ever-expanding compendium of experimental and clinical studies, this review details the current state-of-play and provides a perspective of chromatin-dependent mechanisms implicated in diabetic complications, with a special focus on diabetic nephropathy. We hypothesise a codified signature of the diabetic epigenome and provide examples of prime candidates for chemical modification. As for the pharmacological control of epigenetic marks, we explore future strategies to expedite and refine the search for clinically relevant discoveries. We also consider the challenges associated with therapeutic strategies targeting epigenetic pathways. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-017-4490-1) contains a slideset of the figures for download, which is available to authorised users. Springer Berlin Heidelberg 2017-11-11 2018 /pmc/articles/PMC6448927/ /pubmed/29128937 http://dx.doi.org/10.1007/s00125-017-4490-1 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Keating, Samuel T.
van Diepen, Janna A.
Riksen, Niels P.
El-Osta, Assam
Epigenetics in diabetic nephropathy, immunity and metabolism
title Epigenetics in diabetic nephropathy, immunity and metabolism
title_full Epigenetics in diabetic nephropathy, immunity and metabolism
title_fullStr Epigenetics in diabetic nephropathy, immunity and metabolism
title_full_unstemmed Epigenetics in diabetic nephropathy, immunity and metabolism
title_short Epigenetics in diabetic nephropathy, immunity and metabolism
title_sort epigenetics in diabetic nephropathy, immunity and metabolism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448927/
https://www.ncbi.nlm.nih.gov/pubmed/29128937
http://dx.doi.org/10.1007/s00125-017-4490-1
work_keys_str_mv AT keatingsamuelt epigeneticsindiabeticnephropathyimmunityandmetabolism
AT vandiepenjannaa epigeneticsindiabeticnephropathyimmunityandmetabolism
AT riksennielsp epigeneticsindiabeticnephropathyimmunityandmetabolism
AT elostaassam epigeneticsindiabeticnephropathyimmunityandmetabolism